Matches in Nanopublications for { ?s ?p "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.
- NP306921.RAlz_DNcwpVxLHjKhea1m1yvR71CFiamWz6Yf9CBXQt_E130_assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306921.RAlz_DNcwpVxLHjKhea1m1yvR71CFiamWz6Yf9CBXQt_E130_provenance.
- NP641494.RAgEO8vJioIfSs8NxKHon7gVzjJ7OalWq2fktwRooI6qY130_assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641494.RAgEO8vJioIfSs8NxKHon7gVzjJ7OalWq2fktwRooI6qY130_provenance.